187 related articles for article (PubMed ID: 7699658)
1. Calcium pyrophosphate dihydrate (CPPD) crystal dissolution by alkaline phosphatase: interaction of alkaline phosphatase on CPPD crystals.
Shinozaki T; Xu Y; Cruz TF; Pritzker KP
J Rheumatol; 1995 Jan; 22(1):117-23. PubMed ID: 7699658
[TBL] [Abstract][Full Text] [Related]
2. Polyamines enhance calcium pyrophosphate dihydrate crystal dissolution.
Shinozaki T; Pritzker KP
J Rheumatol; 1995 Oct; 22(10):1907-12. PubMed ID: 8991990
[TBL] [Abstract][Full Text] [Related]
3. Regulation of alkaline phosphatase: implications for calcium pyrophosphate dihydrate crystal dissolution and other alkaline phosphatase functions.
Shinozaki T; Pritzker KP
J Rheumatol; 1996 Apr; 23(4):677-83. PubMed ID: 8730126
[TBL] [Abstract][Full Text] [Related]
4. Alkaline phosphatase dissolves calcium pyrophosphate dihydrate crystals.
Xu Y; Cruz TF; Pritzker KP
J Rheumatol; 1991 Oct; 18(10):1606-10. PubMed ID: 1765989
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease.
So PP; Tsui FW; Vieth R; Tupy JH; Pritzker KP
J Rheumatol; 2007 Jun; 34(6):1313-22. PubMed ID: 17516619
[TBL] [Abstract][Full Text] [Related]
6. Characterization of chondrocyte alkaline phosphatase as a potential mediator in the dissolution of calcium pyrophosphate dihydrate crystals.
Xu Y; Pritzker KP; Cruz TF
J Rheumatol; 1994 May; 21(5):912-9. PubMed ID: 8064734
[TBL] [Abstract][Full Text] [Related]
7. Mercaptopyruvate inhibits tissue-nonspecific alkaline phosphatase and calcium pyrophosphate dihydrate crystal dissolution.
Kannampuzha JV; Tupy JH; Pritzker KP
J Rheumatol; 2009 Dec; 36(12):2758-65. PubMed ID: 19884277
[TBL] [Abstract][Full Text] [Related]
8. Effects of pyrophosphatase on dissolution of calcium pyrophosphate dihydrate crystals.
Xu Y; Cruz T; Cheng PT; Pritzker KP
J Rheumatol; 1991 Jan; 18(1):66-71. PubMed ID: 1850802
[TBL] [Abstract][Full Text] [Related]
9. Calcium pyrophosphate crystal deposition: the effect of monosodium urate and apatite crystals in a kinetic study using a gelatin matrix model.
Mandel GS; Halverson PB; Mandel NS
Scanning Microsc; 1988 Jun; 2(2):1189-98. PubMed ID: 2840735
[TBL] [Abstract][Full Text] [Related]
10. [The solubility of calcium pyrophosphate dihydrate crystals].
Sakamoto H
Nihon Seikeigeka Gakkai Zasshi; 1995 Jul; 69(7):484-92. PubMed ID: 7561350
[TBL] [Abstract][Full Text] [Related]
11. Calcium pyrophosphate crystal deposition: a kinetic study using a type I collagen gel model.
Mandel GS; Halverson PB; Rathburn M; Mandel NS
Scanning Microsc; 1990 Mar; 4(1):175-9; discussion 179-80. PubMed ID: 2164257
[TBL] [Abstract][Full Text] [Related]
12. Calcium pyrophosphate crystal formation in aqueous solutions.
Cheng PT; Pritzker KP; Adams ME; Nyburg SC; Omar SA
J Rheumatol; 1980; 7(5):609-16. PubMed ID: 6255159
[TBL] [Abstract][Full Text] [Related]
13. Calcium pyrophosphate crystal deposition in hyaline cartilage. Ultrastructural analysis and implications for pathogenesis.
Pritzker KP; Cheng PT; Renlund RC
J Rheumatol; 1988; 15(5):828-35. PubMed ID: 2845077
[TBL] [Abstract][Full Text] [Related]
14. A model for human calcium pyrophosphate crystal deposition disease: crystallization kinetics in a gelatin matrix.
Mandel NS; Mandel GS
Scan Electron Microsc; 1984; (Pt 4):1779-92. PubMed ID: 6098005
[TBL] [Abstract][Full Text] [Related]
15. Calcium pyrophosphate crystal deposition: the effect of soluble iron in a kinetic study using a gelatin matrix model.
Mandel GS; Halverson PB; Mandel NS
Scanning Microsc; 1988 Jun; 2(2):1177-88. PubMed ID: 2840734
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of low density lipoprotein on the inflammation-inducing activity of calcium pyrophosphate dihydrate crystals.
Kumagai Y; Watanabe W; Kobayashi A; Sato K; Onuma S; Sakamoto H
J Rheumatol; 2001 Dec; 28(12):2674-80. PubMed ID: 11764217
[TBL] [Abstract][Full Text] [Related]
17. Characterization and membranolytic effects of triclinic calcium pyrophosphate dihydrate crystals.
Burt HM; Jackson JK
J Rheumatol; 1987 Oct; 14(5):968-73. PubMed ID: 2828618
[TBL] [Abstract][Full Text] [Related]
18. [New knowledge on the calcium pyrophosphate dihydrate (CPPD) crystal deposition disease in the cervical ligamentum flavum].
Kawano N; Matsuno T; Miyazawa S; Uchiyama H; Ohtaka H; Mii K; Tachibana S
No Shinkei Geka; 1987 Feb; 15(2):181-90. PubMed ID: 3031524
[TBL] [Abstract][Full Text] [Related]
19. The utility of alizarin red s staining in calcium pyrophosphate dihydrate crystal deposition disease.
Yamakawa K; Iwasaki H; Masuda I; Ohjimi Y; Honda I; Saeki K; Zhang J; Shono E; Naito M; Kikuchi M
J Rheumatol; 2003 May; 30(5):1032-5. PubMed ID: 12734902
[TBL] [Abstract][Full Text] [Related]
20. Ferrous [Fe++] but not ferric [Fe] ions inhibit de novo formation of calcium pyrophosphate dihydrate crystals: possible relationships to chondrocalcinosis and hemochromatosis.
Cheng PT; Pritzker KP
J Rheumatol; 1988 Feb; 15(2):321-4. PubMed ID: 2834554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
